Search

Your search keyword '"I, Zamora"' showing total 332 results

Search Constraints

Start Over You searched for: Author "I, Zamora" Remove constraint Author: "I, Zamora"
332 results on '"I, Zamora"'

Search Results

201. Relación entre el índice lipoproteínas de baja densidad (LDL)/lipoproteínas de alta densidad (HDL) con enzimas antioxidantes y el índice oxLDL/HDL.

202. Relationship of the low-density lipoprotein (LDL)/high-density lipoprotein (HDL) index with antioxidant enzymes and with the oxLDL/HDL index.

205. Broad Developmental Screening Misses Young Children With Social-Emotional Needs.

206. Legacy data sharing to improve drug safety assessment: the eTOX project.

207. Software-aided approach to investigate peptide structure and metabolic susceptibility of amide bonds in peptide drugs based on high resolution mass spectrometry.

208. Developmental Screening and Referrals: Assessing the Influence of Provider Specialty, Training, and Interagency Communication.

209. Development, optimization and implementation of a centralized metabolic soft spot assay.

210. Parent-Reported Strengths in Children with Autism Spectrum Disorders at the Time of an Interdisciplinary Diagnostic Evaluation.

211. Attention deficit hyperactivity disorder: From parents to children.

212. Triglyceride/high-density lipoprotein cholesterol (TG/HDL-C) index as a reference criterion of risk for metabolic syndrome (MetS) and low insulin sensitivity in apparently healthy subjects.

213. Analysis of cytokine gene polymorphisms in Mestizo and native populations from Mexico.

214. Phenotype of 7q11.23 duplication: A family clinical series.

215. Modeling Organic Anion-Transporting Polypeptide 1B1 Inhibition to Elucidate Interaction Risks in Early Drug Design.

216. Aggression in Autism Spectrum Disorder: Supporting the Entire Family.

217. Rifamycin Resistance in Clostridium difficile Is Generally Associated with a Low Fitness Burden.

218. PARALLEL MODELS OF ASSESSMENT: INFANT MENTAL HEALTH AND THERAPEUTIC ASSESSMENT MODELS INTERSECT THROUGH EARLY CHILDHOOD CASE STUDIES.

219. Association of the Metabolic Syndrome with Antioxidant Defense and Outstanding Superoxide Dismutase Activity in Mexican Subjects.

220. Cell Type-Specific Circuit Mapping Reveals the Presynaptic Connectivity of Developing Cortical Circuits.

221. Brief Report: Recruitment and Retention of Minority Children for Autism Research.

222. Software-aided cytochrome P450 reaction phenotyping and kinetic analysis in early drug discovery.

223. Software-aided structural elucidation in drug discovery.

224. Post-acquisition analysis of untargeted accurate mass quadrupole time-of-flight MS(E) data for multiple collision-induced neutral losses and fragment ions of glutathione conjugates.

225. Glutathione peroxidase 3 serum levels and GPX3 gene polymorphisms in subjects with metabolic syndrome.

226. Tumor necrosis factor haplotype diversity in Mestizo and native populations of Mexico.

227. Early decrease of insulin sensitivity in offspring of individuals with type 2 diabetes. The Mexican Diabetes Prevention Study.

228. Fragment-based design for the development of N-domain-selective angiotensin-1-converting enzyme inhibitors.

229. Autism assessment in children with optic nerve hypoplasia and other vision impairments.

230. Promoter polymorphisms of ST3GAL4 and ST6GAL1 genes and associations with risk of premalignant and malignant lesions of the cervix.

231. How sex of children with autism spectrum disorders and access to treatment services relates to parental stress.

232. Low prevalence of interleukin-6 haplotypes associated with a decreased risk of type 2 diabetes in Mexican subjects with a family history of type 2 diabetes.

233. Software automation tools for increased throughput metabolic soft-spot identification in early drug discovery.

234. Update on hydrocodone metabolites in rats and dogs aided with a semi-automatic software for metabolite identification Mass-MetaSite.

235. High-throughput, computer assisted, specific MetID. A revolution for drug discovery.

236. Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria.

237. Serum levels of glutathione peroxidase 3 in overweight and obese subjects from central Mexico.

238. They are not just little adults: angioembolization improves salvage of high grade IV-V blunt splenic injuries in adults but not in pediatric patients.

239. Risk factors for diabetes, but not for cardiovascular disease, are associated with family history of Type 2 diabetes in subjects from central Mexico.

240. Environmental temperature affects prevalence of blood parasites of birds on an elevation gradient: implications for disease in a warming climate.

242. Enhanced metabolite identification with MS(E) and a semi-automated software for structural elucidation.

243. β-cell function is associated with metabolic syndrome in Mexican subjects.

244. The challenges of in silico contributions to drug metabolism in lead optimization.

245. Nephrin mutations cause childhood- and adult-onset focal segmental glomerulosclerosis.

246. TRPC6 mutational analysis in a large cohort of patients with focal segmental glomerulosclerosis.

247. Suitability of GRIND-based principal properties for the description of molecular similarity and ligand-based virtual screening.

248. SHOP: receptor-based scaffold HOPping by GRID-based similarity searches.

249. SHOP: a method for structure-based fragment and scaffold hopping.

250. Molecular architecture of the centriole proteome: the conserved WD40 domain protein POC1 is required for centriole duplication and length control.

Catalog

Books, media, physical & digital resources